Asteroid Ointment
NDC Package 84107-552-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Asteroid (menthol, petrolatum, zinc oxide) ointment is adults: Apply externally to the affected area up to 4 times daily, especially at night, in the morning or after each bowel movement. This formulation utilizes a ointment delivery system. Marketed by Healthtex Limited, this product is identified by NDC 84107-552 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
84107-552-02
Package Description
1 TUBE in 1 CARTON / 28 g in 1 TUBE
Product Code
84107-552
11-Digit Billing Format
84107055202
RxNorm Crosswalk
  • RxCUI: 2720028 - menthol 0.35 % / petrolatum 79.65 % / zinc oxide 5 % Rectal Ointment
  • RxCUI: 2720028 - menthol 0.0035 MG/MG / petrolatum 0.797 MG/MG / zinc oxide 0.05 MG/MG Rectal Ointment
  • RxCUI: 2720028 - menthol 0.0035 MG/MG / petrolatum 0.797 MG/MG / ZNO 0.05 MG/MG Rectal Ointment

Clinical Specifications

Proprietary Name
Asteroid
Non-Proprietary Name
Menthol, Petrolatum, Zinc Oxide
Substance Name
Menthol; Petrolatum; Zinc Oxide
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
Adults: Apply externally to the affected area up to 4 times daily, especially at night, in the morning or after each bowel movement.

Regulatory & Marketing

Labeler Name
Healthtex Limited
Product Type
Human Otc Drug
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-22-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84107-552-02 identifies a specific commercial package of 1 tube in 1 carton / 28 g in 1 tube of Asteroid, a human over the counter drug labeled by Healthtex Limited. This ointment is formulated for topical use and contains menthol; petrolatum; zinc oxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Healthtex Limited on July 22, 2025. The current certification is valid through December 31, 2026.

How is this Healthtex Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84107055202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84107-552-02
11-Digit CMS (5-4-2)
84107-0552-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.